{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05571865",
            "orgStudyIdInfo": {
                "id": "00002"
            },
            "secondaryIdInfos": [
                {
                    "id": "PA-20-190",
                    "type": "OTHER",
                    "domain": "NIH"
                }
            ],
            "organization": {
                "fullName": "University of Louisville",
                "class": "OTHER"
            },
            "briefTitle": "Diabetic Cardiomyopathy and Heart Failure",
            "officialTitle": "Preventing Diabetic Cardiomyopathy and Heart Failure by Ketone Bodies",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "diabetic-cardiomyopathy-and-heart-failure"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-10",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-09-16",
            "studyFirstSubmitQcDate": "2022-10-05",
            "studyFirstPostDateStruct": {
                "date": "2022-10-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-10-05",
            "lastUpdatePostDateStruct": {
                "date": "2022-10-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Mahavir Singh, DVM, MS, PhD",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Louisville"
            },
            "leadSponsor": {
                "name": "Mahavir Singh, DVM, MS, PhD",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will demonstrate the beneficial effects of ketone bodies in type 1 diabetes (T1D) patients and will have significant translational applications to prevent serious metabolic conditions such as T1D induced diabetic cardiomyopathy (DCM).",
            "detailedDescription": "T1D remains the primary cause of DCM. The long-term goal is to understand the mechanism of T1D leading to DCM. Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in degrading the low-density lipoprotein receptors (LDLRs) and that increases the circulating LDL cholesterol (LDL-C). Further, PCSK9 increases duringT1D and that, in turn, decreases mitochondrial bioenergetics, transcription factor- mitochondrial (TFAM), and the mitochondrial numbers thus creates an oxidative stress. These changes lead to oxidation of high-density lipoprotein paraoxonase-1 (HDL-Pon1). Because Pon1 hydrolyzes homocysteine (Hcy), the oxidized Pon1 thus causes accumulation of Hcy (i.e. hyperhomocysteinemia; HHcy). Also, the 'metabolic memory' is associated with epigenetic modification (methylation) of genes encoding proteins such as thioredoxin interacting protein (TXNIP). Since methylation/epigenetics inhibits genes, this phenomenon generates even more amounts of Hcy. Investigators have shown that HHcy decreases G-protein coupled receptor (GPCR) G\u03b1s subunit, protein kinase-B (AKT), focal adhesion kinase (FAK) but increases calpain-1, inflammasome and oxidative stress. The central hypothesis is that an increase in PCSK9 causes oxidative stress and decreases TXNIP thus causing oxidation of HDL-Pon1 and subsequent accumulation of Hcy. These alterations lead to decrease in G\u03b1s, AKT, FAK and concomitant increase in PCSK9 and calpain-1 causing metabolic, diastolic, and systolic cardiac dysfunction. Treatment with ketone bodies (the food for mitochondria) will mitigate these changes."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetic Cardiomyopathies",
                "Heart Failure"
            ],
            "keywords": [
                "Diabetic Cardiomyopathy, Metabolic Dysregulation, and Heart Failure."
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Diabetic, and non-diabetic subjects.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Control subjects (non-diabetic).",
                    "type": "OTHER",
                    "description": "Control subjects (non-diabetic):\n\n10 subjects: No intervention (placebo). 10 subjects: Intervention (probiotic)",
                    "interventionNames": [
                        "Dietary Supplement: Probiotic"
                    ]
                },
                {
                    "label": "Diabetic Subjects",
                    "type": "OTHER",
                    "description": "Diabetic subjects:\n\n10 subjects: No intervention (placebo). 10 subjects: Intervention (probiotic)",
                    "interventionNames": [
                        "Dietary Supplement: Probiotic"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Probiotic",
                    "description": "Oral administration of a probiotic",
                    "armGroupLabels": [
                        "Control subjects (non-diabetic).",
                        "Diabetic Subjects"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Outcome Measure-I",
                    "description": "Levels of glucose in blood and urine",
                    "timeFrame": "4 years"
                },
                {
                    "measure": "Primary Outcome Measure-II",
                    "description": "Cardiac function evaluation by electrocardiogram",
                    "timeFrame": "4 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Secondary Outcome Measure-I",
                    "description": "Biochemical estimation of biomarkers from blood samples",
                    "timeFrame": "4 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n-Diabetic subjects with high blood glucose levels\n\nExclusion Criteria:\n\n- Comorbidities affecting glucose levels and cardiac function",
            "healthyVolunteers": true,
            "sex": "ALL",
            "genderBased": true,
            "genderDescription": "Both male and female representing race/ethnicity",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mahavir Singh, DVM, MS, PhD",
                    "role": "CONTACT",
                    "phone": "(502) 403-4125",
                    "email": "mahavir.singh@louisville.edu"
                },
                {
                    "name": "Sri Prakash L. Mokshagundam, MD",
                    "role": "CONTACT",
                    "phone": "(502) 852-5237",
                    "email": "sriprakash.mokshagundam@louisville.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mahavir Singh, DVM, MS, PhD",
                    "affiliation": "University of Louisville School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Louisville School of Medicine",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mahavir Singh, DVM, MS, PhD",
                            "role": "CONTACT",
                            "phone": "502-403-4125",
                            "email": "mahavir.singh@louisville.edu"
                        },
                        {
                            "name": "Sri Prakash L. Mokshagundam, MD",
                            "role": "CONTACT",
                            "phone": "(502) 852-5237",
                            "email": "sriprakash.mokshagundam@louisville.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "30832381",
                    "type": "RESULT",
                    "citation": "Mishra SP, Wang S, Nagpal R, Miller B, Singh R, Taraphder S, Yadav H. Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives. Microorganisms. 2019 Mar 2;7(3):67. doi: 10.3390/microorganisms7030067."
                },
                {
                    "pmid": "35299968",
                    "type": "RESULT",
                    "citation": "Wang CH, Yen HR, Lu WL, Ho HH, Lin WY, Kuo YW, Huang YY, Tsai SY, Lin HC. Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus. Front Endocrinol (Lausanne). 2022 Mar 1;13:754401. doi: 10.3389/fendo.2022.754401. eCollection 2022."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Outcomes of the probiotic intervention in diabetic patients for the prevention of cardiomyopathy.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "As soon as the data is collected, and fully analyzed.",
            "accessCriteria": "Via personal meetings, national and international conferences."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006333",
                    "term": "Heart Failure"
                },
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                },
                {
                    "id": "D000058065",
                    "term": "Diabetic Cardiomyopathies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9421",
                    "name": "Heart Failure",
                    "asFound": "Heart Failure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28963",
                    "name": "Diabetic Cardiomyopathies",
                    "asFound": "Diabetic Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        }
    },
    "hasResults": false
}